Dyne Therapeutics (NYSE:DYN) Earns Hold Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Dyne Therapeutics (NYSE:DYNGet Rating) in a research note released on Thursday. The brokerage issued a hold rating on the stock.

Dyne Therapeutics Price Performance

Shares of NYSE DYN opened at $12.26 on Thursday. Dyne Therapeutics has a 1 year low of $4.30 and a 1 year high of $15.63.

Featured Stories

Receive News & Ratings for Dyne Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dyne Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.